Sign in to view content

Complete and early vitrectomy with intravitreal moxifloxacin/dexamethasone for endophthalmitis

Raul Velez-Montoya, MD

Video
Published 2019

Related

Becoming a Clinical Trialist
Nancy M. Holekamp, MD, FASRS
Updates from the Field
2022
APX3330, an Oral Drug in Trial for DR and DME, Demonstrated a Favorable Safety and Tolerability Profile in Multiple Phase 1 and 2 Studies
Michael J Allingham, MD, PhD
Annual Meeting Talks
2021
Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Carl J Danzig, MD
Updates from the Field
2022

Category: Inflammatory and Infectious Diseases

See more